New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the nonprofit.

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Huge pressure' The report from Dr Brink said the island needed to focus on preventing illnesses as well as treating them. Mrs Thompson said high low-density lipoprotein cholester

A new study found that roughly 4 in 10 people over the age of 55 are likely to develop dementia. The Alzheimer’s Association says it’s one of the most expensive medical conditions.

People who care for patients with Alzheimer's or other dementia must be alert when winter weather turns dangerous, advises the Nebraska Alzheimer's Association.

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant age-related TDP-43 encephalopathy (LATE) have just been published.

Related: How Following the Mediterranean Diet Could Reduce Brain Age by 50%, According to a New Study For this study, researchers hypothesized that moderate dietary intake of choline would be associated with lower odds of developing dementia and mild cognitive impairment.

Across Iowa, 11% of people, 65 or older, have Alzheimer's. That number is even higher in rural counties. Here's how you can get support, with a virtual forum.

A new study clams dementia cases will double by 2060. Here’s what experts believe could be driving the rise in dementia rates and what you can do to help prevent it.

However, in people with mild cognitive impairment, the presence of depressive symptoms was tied to a lower likelihood of amyloid pathology (OR 0.73, 95% CI 0.61-0.89, P =0.001), Oomens and colleagues said in JAMA Psychiatry.

Broad classes of drugs, including antibiotics, antivirals, vaccines, anti-inflammatories and antihypertensives, were associated with a lower risk for dementia in a large analysis.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.